| Event |
Timezone:
 Australia/Sydney |
 |
AAH - CEO Profile - Dr Steffen Nock, Acting CEO Mon, 15 Dec 2008 8:30am
|
|
 |
AAH - Arana Commences International Phase II Rheumatoid Arthritis Trial - Dr David Fuller, Chief Medical Officer Thu, 11 Dec 2008 8:30am
|
|
 |
Grand Opening Melbourne Facility: Steffen Nock & Rob Crombie Speech Wed, 19 Nov 2008 9:30am
|
|
 |
AAH - Grand Opening Melbourne Facility - Innovation Minister Gavin Jennings Speech Wed, 19 Nov 2008 9:00am
|
|
 |
AAH - Full Year Results 2008 - Mr Robin Beaumont, Chairman and Mr Niall Henderson, CFO Thu, 13 Nov 2008 3:30pm
|
|
| |
AAH - FDA Accepts Arana's Anti-Inflammatory IND - Dr David Fuller, Chief Medical Officer Tue, 4 Nov 2008 8:30am
|
|
| |
AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer Thu, 28 Aug 2008 4:30pm
|
|
 |
AAH - 6th Annual Australian Biotechnology Summit 2008, Corporate Overview - Dr John Chiplin, CEO Wed, 6 Aug 2008 3:45pm
|
|
 |
AAH - Grand Opening Macquarie Park Facility - Senator The Hon Kim Carr, Minister for Innovation, Industry, Science and Research Thu, 3 Jul 2008 12:15pm
|
|
| |
AAH - Grand Opening Macquarie Park Facility - Dr John Chiplin, CEO Thu, 3 Jul 2008 12:00pm
|
|
 |
AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc Tue, 24 Jun 2008 4:00pm
|
|
 |
AAH - Arana Reports Strong Financial Position - Dr John Chiplin Managing Director, CEO and Mr Niall Henderson CFO Thu, 22 May 2008 3:30pm
|
|
 |
AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug - Dr Cliff Holloway, Vice President of Business Development Mon, 28 Apr 2008 3:35pm
|
|
| |
Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics Wed, 23 Apr 2008 12:15pm
|
|
 |
AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer Tue, 18 Mar 2008 2:00pm
|
|
| |
AAH - Sky TV Update on Phase II Trial Status - Dr John Chiplin, CEO Tue, 18 Mar 2008 11:00am
|
|
| |
AAH - Announes Phase II Trials for Lead Compound ART621 - Dr David Fuller, Chief Medical Officer Wed, 5 Dec 2007 11:00am
|
|
 |
AAH - Arana Therapeutics Completes Project With CSL - Dr Rob Crombie, VP Business Development Fri, 30 Nov 2007 11:40am
|
|
| |
AAH - New Direction, New Name, New Future - Dr John Chiplin, CEO Thu, 8 Nov 2007 11:30am
|
|
 |
[PTD] PTD - Shareholders Approve Peptech-Evogenix Merger - Dr John Chiplin, CEO Thu, 9 Aug 2007 3:00pm
|
|
|
|
